Human Longevity, Celgene Ink Placental Stem Cell Deal – Genetic Engineering & Biotechnology News

Human Longevity, Celgene Ink Placental Stem Cell DealGenetic Engineering & Biotechnology NewsHuman Longevity (HLI), the genomics and cell therapy-based diagnostic and therapeutic company that J. Craig Venter, Ph.D., recently co-founded, has made a deal with Celgene Cellular Therapeutics (CCT) to license, develop, and co-promote Celgene's
http://blog.zandcell.com/human-longevity-celgene-ink-placental-stem-cell-deal-genetic-engineering-biotechnology-news/?utm_source=rss&utm_medium=rss&utm_campaign=human-longevity-celgene-ink-placental-stem-cell-deal-genetic-engineering-biotechnology-news